tiprankstipranks
Oncopeptides AB (GB:0RN4)
LSE:0RN4
UK Market

Oncopeptides AB (0RN4) Share Forecast & Price Target

2 Followers
See the Price Targets and Ratings of:

0RN4 Analyst Ratings

Currently, no data available
Based on NaN analysts giving stock ratings to
Oncopeptides
AB
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

0RN4 Stock 12 Month Forecast

There Are No Analyst Ratings for GB:0RN4 In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

0RN4 Financial Forecast

0RN4 Earnings Forecast

The previous quarter’s earnings for 0RN4 were -kr0.14.
The previous quarter’s earnings for 0RN4 were -kr0.14.

0RN4 Sales Forecast

Next quarter’s sales forecast for 0RN4 is kr32.00M with a range of kr32.00M to kr32.00M. The previous quarter’s sales results were kr31.10M. 0RN4 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 63.25% of the time in the same period. In the last calendar year 0RN4 has Performed in-line its overall industry.
Next quarter’s sales forecast for 0RN4 is kr32.00M with a range of kr32.00M to kr32.00M. The previous quarter’s sales results were kr31.10M. 0RN4 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 63.25% of the time in the same period. In the last calendar year 0RN4 has Performed in-line its overall industry.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks - xAI Analyst forecast on GB:0RN4
TipRanks - xAI
TipRanks - xAI
kr1.5kr2
Hold
25.00%
Upside
Reiterated
08/28/26
AI Generated ArticleAI Generated Article
TipRanks - OpenAI Analyst forecast on GB:0RN4
TipRanks - OpenAI
TipRanks - OpenAI
kr1.5kr2
Hold
25.00%
Upside
Reiterated
08/28/26
AI Generated ArticleAI Generated Article
TipRanks - Google Analyst forecast on GB:0RN4
TipRanks - Google
TipRanks - Google
kr1.5kr2
Hold
25.00%
Upside
Reiterated
08/28/26
AI Generated ArticleAI Generated Article
TipRanks - PerPlexity Analyst forecast on GB:0RN4
TipRanks - PerPlexity
TipRanks - PerPlexity
kr1.5kr2
Hold
25.00%
Upside
Reiterated
08/28/26
AI Generated ArticleAI Generated Article
TipRanks - DeepSeek Analyst forecast on GB:0RN4
TipRanks - DeepSeek
TipRanks - DeepSeek
kr1.5kr2
Hold
25.00%
Upside
Reiterated
08/28/26
AI Generated ArticleAI Generated Article
TipRanks - Anthropic Analyst forecast on GB:0RN4
TipRanks - Anthropic
TipRanks - Anthropic
kr1.5kr2
Hold
25.00%
Upside
Reiterated
08/28/26
AI Generated ArticleAI Generated Article
Analyst Type
Any
Any
AI Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks - xAI Analyst forecast on GB:0RN4
TipRanks - xAI
TipRanks - xAI
kr1.5kr2
Hold
25.00%
Upside
Reiterated
08/28/26
AI Generated ArticleAI Generated Article
TipRanks - OpenAI Analyst forecast on GB:0RN4
TipRanks - OpenAI
TipRanks - OpenAI
kr1.5kr2
Hold
25.00%
Upside
Reiterated
08/28/26
AI Generated ArticleAI Generated Article
TipRanks - Google Analyst forecast on GB:0RN4
TipRanks - Google
TipRanks - Google
kr1.5kr2
Hold
25.00%
Upside
Reiterated
08/28/26
AI Generated ArticleAI Generated Article
TipRanks - PerPlexity Analyst forecast on GB:0RN4
TipRanks - PerPlexity
TipRanks - PerPlexity
kr1.5kr2
Hold
25.00%
Upside
Reiterated
08/28/26
AI Generated ArticleAI Generated Article
TipRanks - DeepSeek Analyst forecast on GB:0RN4
TipRanks - DeepSeek
TipRanks - DeepSeek
kr1.5kr2
Hold
25.00%
Upside
Reiterated
08/28/26
AI Generated ArticleAI Generated Article
TipRanks - Anthropic Analyst forecast on GB:0RN4
TipRanks - Anthropic
TipRanks - Anthropic
kr1.5kr2
Hold
25.00%
Upside
Reiterated
08/28/26
AI Generated ArticleAI Generated Article
Stocks with the Highest Top Analyst Consensus in the General Sector
STDNStandard Nuclear
SKHYSK Hynix
ITGITG Inc. Class A
LIMENeutron Holdings, Inc.
EROCERock
Find stocks in the General sector that are highly recommended by Top Performing Analysts.

0RN4 Analyst Recommendation Trends

Rating
Apr 26
May 26
Jun 26
Jul 26
Aug 26
Strong Buy
0
0
0
0
0
Buy
0
0
0
0
0
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
0
0
0
0
0
In the current month, 0RN4 has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 0RN4 average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.

0RN4 Stock Forecast FAQ

What is GB:0RN4’s average 12-month price target, according to analysts?
Currently, no data Available
What is GB:0RN4’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for GB:0RN4, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is Oncopeptides AB a Buy, Sell or Hold?
      Currently, no data Available
      What is Oncopeptides AB’s share price target?
      Currently, no data Available
      What do analysts say about Oncopeptides AB?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of Oncopeptides AB?
      To buy shares of GB:0RN4, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.